Your browser doesn't support javascript.
loading
Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs.
Nakai, Sho; Yamada, Shutaro; Outani, Hidetatsu; Nakai, Takaaki; Yasuda, Naohiro; Mae, Hirokazu; Imura, Yoshinori; Wakamatsu, Toru; Tamiya, Hironari; Tanaka, Takaaki; Hamada, Kenichiro; Tani, Akiyoshi; Myoui, Akira; Araki, Nobuhito; Ueda, Takafumi; Yoshikawa, Hideki; Takenaka, Satoshi; Naka, Norifumi.
Afiliación
  • Nakai S; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Yamada S; Department of Orthopaedic Surgery, Yao Municipal Hospital, 1-3-1 Ryugecho, Yao, Osaka, 581-0069, Japan.
  • Outani H; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Nakai T; Department of Orthopaedic Surgery, Kawachi General Hospital, 1-31 Yokomakura, Higashiosaka, Osaka, 578-0954, Japan.
  • Yasuda N; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Mae H; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Imura Y; Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Wakamatsu T; Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Tamiya H; Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Tanaka T; Musculoskeletal Oncology Service, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.
  • Hamada K; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Tani A; Compound Library Screening Center, Osaka University Graduate School of Pharmaceutical Sciences, 1-6 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Myoui A; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Araki N; Department of Orthopaedic Surgery, Ashiya Municipal Hospital, 39-1 Asahigaokacho, Ashiya, Hyogo, 659-8502, Japan.
  • Ueda T; Department of Orthopaedic Surgery, Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka, 540-0006, Japan.
  • Yoshikawa H; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
  • Takenaka S; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. s.takenaka.0816@ort.med.osaka-u.ac.jp.
  • Naka N; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Sci Rep ; 9(1): 15812, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31676869

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Receptor IGF Tipo 1 / Neoplasias Pulmonares / Metástasis de la Neoplasia Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma / Receptor IGF Tipo 1 / Neoplasias Pulmonares / Metástasis de la Neoplasia Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido